Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
  Home Print this page Email this page Small font sizeDefault font sizeIncrease font size Users Online: 597  

 
   Table of Contents      
LETTER TO EDITOR
Year : 2020  |  Volume : 19  |  Issue : 2  |  Page : 179

Clinical significance of thyroid incidentalomas detected on fluorodeoxyglucose positron emission tomography scan (PETomas): Its original description and now


1 Division of Endocrinology, McGill University Health Center, Montreal, Quebec, Canada
2 Department of Surgery, McGill University Health Center, Montreal, Quebec, Canada

Date of Submission05-Jan-2020
Date of Acceptance23-Jan-2020
Date of Web Publication11-Jun-2020

Correspondence Address:
Dr. Elliot J Mitmaker
Department of Surgery, Section of Endocrine Surgery, McGill University Health Centre, Royal Victoria Hospital, Glen Site, 1001 Boul Decarie, Bureau D02.7324,Montréal, Québec H4A 3J1
Canada
Login to access the Email id


DOI: 10.4103/wjnm.WJNM_2_20

Rights and Permissions

How to cite this article:
How J, Tabah R, Mitmaker EJ. Clinical significance of thyroid incidentalomas detected on fluorodeoxyglucose positron emission tomography scan (PETomas): Its original description and now. World J Nucl Med 2020;19:179

How to cite this URL:
How J, Tabah R, Mitmaker EJ. Clinical significance of thyroid incidentalomas detected on fluorodeoxyglucose positron emission tomography scan (PETomas): Its original description and now. World J Nucl Med [serial online] 2020 [cited 2020 Jul 12];19:179. Available from: http://www.wjnm.org/text.asp?2020/19/2/179/286461



Dear Editor,

We read with much interest the paper,[1] “Clinical significance of thyroid incidentalomas detected on fluorodeoxyglucose positron emission tomography scan (PETomas): An Indian experience” by Kumar et al. published in the July–September 2019 issue of your journal. In April 2011, our team published our findings on this topic, at which time we suggested that this thyroid entity should be called “PETomas.”[2] We are, therefore, extremely surprised that Kumar et al. did not cite our publication and acknowledge our role in initiating the use of the term “PETomas.”

We would also like to draw the attention of your readers to a paper published in 2008 by Katz and Shaha of the Memorial Sloan-Kettering Cancer Center, wherein they proposed that this thyroid finding should be called “PET-associated incidental neoplasms (PAINS).”[3] Neither “PAINS” nor “PETomas” have thus far caught on in the literature so that we heartily welcome the usage of “PETomas” by Kumar et al. We believe that this term is simple and meaningful.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.



 
   References Top

1.
Kumar AA, Datta G, Singh H, Mukherjee PB, Vangal S. Clinical significance of thyroid incidentalomas detected on fluorodeoxyglucose positron emission tomography scan (PETomas): An Indian experience. World J Nucl Med 2019;18:273-82.  Back to cited text no. 1
[PUBMED]  [Full text]  
2.
Nishimori H, Tabah R, Hickeson M, How J. Incidental thyroid “PETomas”: Clinical significance and novel description of the self-resolving variant of focal FDG-PET thyroid uptake. Can J Surg 2011;54:83-8.  Back to cited text no. 2
    
3.
Katz SC, Shaha A. PET-associated incidental neoplasms of the thyroid. J Am Coll Surg 2008;207:259-64.  Back to cited text no. 3
    




 

Top
 
 
  Search
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this article
    References

 Article Access Statistics
    Viewed52    
    Printed1    
    Emailed0    
    PDF Downloaded16    
    Comments [Add]    

Recommend this journal